サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1708016

ギランバレー症候群診断の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Guillain Barre Syndrome Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 180 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ギランバレー症候群診断の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月15日
発行: Persistence Market Research
ページ情報: 英文 180 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のギランバレー症候群診断の市場規模は、2025年に1億4,310万米ドルになるとみられ、2025年～2032年の予測期間に3.4%のCAGRで拡大し、2032年には1億8,080万米ドルに達すると予測されています。

ギランバレー症候群診断市場は、この稀ではあるが重篤な神経疾患の検出とモニタリングに使用される一連の診断検査と技術から構成されます。これらの診断には、腰椎穿刺、神経伝導検査、筋電図検査、血液検査、神経機能や免疫反応を評価するその他の高度な技術が含まれます。市場は、自己免疫性神経疾患に対する意識の高まり、感染症や予防接種に関連したGBSの発生率の増加、診断精度とスピードの進歩により拡大しています。

世界のギランバレー症候群診断市場は、いくつかの重要な市場促進要因に後押しされ、著しい成長を遂げています。神経疾患や自己免疫疾患の有病率の上昇、ヘルスケアインフラへのアクセスの向上が、早期かつ正確な診断に対する需要の高まりにつながっています。ヘルスケア機関による啓発キャンペーンや早期診断を促進する政府の取り組みも、市場の成長に寄与しています。さらに、ジカウイルスやCOVID-19に関連するものを含め、ウイルス感染後の神経学的合併症に関する調査や臨床への注目が高まっていることから、強固な診断能力に対するニーズが高まっています。より感度の高いEMGシステムや迅速な血液アッセイなどの技術的進歩が、これらの診断法の採用をさらに後押ししています。

前向きな市場動向にもかかわらず、ギランバレー症候群診断市場の成長軌道を阻害する要因もあります。中低所得国では認知度が低く、神経学的診断の専門知識が不足しているため、早期発見に課題があります。また、特に資金不足のヘルスケアシステムでは、高度な診断法や検査インフラに関連する高額な費用が高額となる可能性があります。さらに、GBSはまれな疾患であるため、診断法開発への大規模な投資が抑止され、地域によっては入手可能性と価格が制限されることもあります。

ギランバレー症候群診断市場は、ヘルスケア投資の増加と神経学に特化した診断センターの世界の拡大により、有望な機会を秘めています。アジア太平洋とラテンアメリカの新興市場は、ヘルスケアへのアクセスとインフラの発展により、有望な成長ポテンシャルを有しています。神経診断におけるAIとデジタルプラットフォームの統合は、より迅速で正確な解釈の可能性を提供します。さらに、診断企業と研究機関のパートナーシップは、バイオマーカーに基づく検査とポイントオブケア診断の技術革新を促進し、患者の転帰を大幅に改善し、市場範囲を拡大することができます。

当レポートでは、世界のギランバレー症候群診断市場について調査し、診断タイプ別、症候群タイプ別、最終用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値のある洞察

第4章 ギランバレー症候群診断市場の見通し

  • 主なハイライト
  • 市場規模の分析と予測
    • 過去の市場規模分析、2019年～2024年
    • 現在の市場規模分析と予測、2025年～2032年
  • ギランバレー症候群診断市場の見通し、診断タイプ別
    • 過去の市場規模分析、診断タイプ別、2019年～2024年
    • 現在の市場規模分析と予測、診断タイプ別、2025年～2032年
    • 市場の魅力分析：診断タイプ別
  • ギランバレー症候群診断市場の見通し、症候群タイプ別
    • 過去の市場規模分析、症候群タイプ別、2019年～2024年
    • 現在の市場規模分析と予測、症候群タイプ別、2025年～2032年
    • 市場の魅力分析：症候群タイプ別
  • ギランバレー症候群診断市場の見通し：最終用途別
    • 過去の市場規模分析、最終用途別、2019年～2024年
    • 現在の市場規模分析と予測、最終用途別、2025年～2032年
    • 市場の魅力分析：最終用途別

第5章 ギランバレー症候群診断市場の見通し、地域別

  • 過去の市場規模分析、地域別、2019年～2024年
  • 現在の市場規模分析と予測、地域別、2025年～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第6章 北米のギランバレー症候群診断市場の見通し

第7章 欧州のギランバレー症候群診断市場の見通し

第8章 東アジアのギランバレー症候群診断市場の見通し

第9章 南アジアおよびオセアニアのギランバレー症候群診断市場の見通し

第10章 ラテンアメリカギランバレー症候群診断市場の見通し

第11章 中東・アフリカにおけるギランバレー症候群診断市場の見通し

第12章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Cadwell Industries, Inc,
    • Alpine Biomed
    • Bionen Medical Devices
    • Cardinal Health
    • Clarity Medical
    • Deymed Diagnostic
    • EMS Biomedical
    • Medtronic
    • Natus Medical Incorporated
    • Nihon Kohden
    • Rochester Electro-Medical（LifeSync）
    • その他

第13章 付録

目次
Product Code: PMRREP35199

Persistence Market Research has recently released a comprehensive report on the global Guillain-Barre Syndrome (GBS) Diagnostics Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Guillain-Barre Syndrome Diagnostics Market Size (2025E): US$ 143.1 Mn
  • Projected Market Value (2032F): US$ 180.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 3.4%

Guillain-Barre Syndrome Diagnostics Market - Report Scope:

The Guillain-Barre Syndrome diagnostics market comprises a range of diagnostic tests and technologies used to detect and monitor this rare but serious neurological disorder. These diagnostics include lumbar punctures, nerve conduction studies, EMG, blood tests, and other advanced techniques to assess nerve function and immune response. The market is expanding due to growing awareness about autoimmune neurological disorders, increasing incidence of GBS linked to infections and vaccinations, and advancements in diagnostic accuracy and speed.

Market Growth Drivers:

The global Guillain-Barre Syndrome diagnostics market is witnessing significant growth, fueled by several critical drivers. Rising prevalence of neurological and autoimmune disorders, coupled with improved access to healthcare infrastructure, has led to greater demand for early and accurate diagnostics. Awareness campaigns by healthcare organizations and government initiatives promoting early diagnosis are also contributing to market growth. Furthermore, increasing research and clinical focus on post-viral neurological complications-including those associated with Zika virus and COVID-19-have heightened the need for robust diagnostic capabilities. Technological advancements such as more sensitive EMG systems and rapid blood assays further bolster the adoption of these diagnostics.

Market Restraints:

Despite positive market trends, certain factors may hinder the growth trajectory of the Guillain-Barre Syndrome diagnostics market. Limited awareness in low- and middle-income countries and a general lack of neurological diagnostic expertise pose challenges to early detection. High costs associated with advanced diagnostic modalities and testing infrastructure can also be prohibitive, especially in underfunded healthcare systems. Moreover, GBS being a rare condition may deter extensive investment in diagnostic development, limiting availability and affordability in some regions.

Market Opportunities:

The GBS diagnostics market holds promising opportunities owing to rising healthcare investments and the expansion of neurology-focused diagnostic centers worldwide. Emerging markets in Asia-Pacific and Latin America present lucrative growth potential due to increasing healthcare access and infrastructure development. Integration of AI and digital platforms in neurodiagnostics offers potential for faster and more accurate interpretations. Moreover, partnerships between diagnostic companies and research institutions can drive innovation in biomarker-based testing and point-of-care diagnostics, significantly improving patient outcomes and expanding the market reach.

Key Questions Answered in the Report:

  • What are the primary factors driving the global Guillain-Barre Syndrome diagnostics market's growth?
  • Which regions and diagnostic segments are experiencing the highest adoption rates?
  • How are innovations in neurodiagnostic tools influencing market dynamics?
  • Who are the key players in the Guillain-Barre Syndrome diagnostics market, and what strategies are they adopting?
  • What are the emerging trends and future projections for the global GBS diagnostics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Guillain-Barre Syndrome diagnostics market, such as Medtronic, Nihon Kohden, Natus Medical Incorporated, and Cadwell Industries, are focusing on product development, precision diagnostics, and global expansion strategies to strengthen their market position. These companies are investing in advanced EMG and nerve conduction systems, AI-assisted diagnostic tools, and strategic partnerships with hospitals and neurology centers. Emphasis on portable and user-friendly diagnostics and expansion into untapped regions further enhances their competitiveness and long-term growth prospects.

Companies Covered in This Report:

  • Cadwell Industries, Inc.
  • Alpine Biomed
  • Bionen Medical Devices
  • Cardinal Health
  • Clarity Medical
  • Deymed Diagnostic
  • EMS Biomedical
  • Medtronic
  • Natus Medical Incorporated
  • Nihon Kohden
  • Rochester Electro-Medical (LifeSync)

Market Segmentation

By Diagnostic Test

  • Lumbar Puncture
  • Nerve Conduction
  • Electromyography (EMG)
  • Blood Test
  • Other

By Syndrome Type

  • Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
  • Miller Fisher Syndrome (MFS)
  • Acute Motor Axonal Neuropathy (AMAN)
  • Others

By End-use

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Specialty Neurology Centers

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Guillain-Barre Syndrome Diagnostics Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Value Chain Analysis
  • 3.2. Diagnostic Type Adoption / Usage Analysis
  • 3.3. Prevalence & Incidence of GBS
  • 3.4. Key Market Players
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Guillain-Barre Syndrome Diagnostics Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Guillain-Barre Syndrome Diagnostics Market Outlook Diagnostic Type
    • 4.3.1. Historical Market Size (US$ Mn) Analysis, By Diagnostic Type, 2019-2024
    • 4.3.2. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
      • 4.3.2.1. Lumbar Puncture
      • 4.3.2.2. Nerve Conduction
      • 4.3.2.3. Electromyography (EMG)
      • 4.3.2.4. Blood Test
      • 4.3.2.5. Other
    • 4.3.3. Market Attractiveness Analysis: Diagnostic Type
  • 4.4. Global Guillain-Barre Syndrome Diagnostics Market Outlook Syndrome Type
    • 4.4.1. Historical Market Size (US$ Mn) Analysis, By Syndrome Type, 2019-2024
    • 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
      • 4.4.2.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
      • 4.4.2.2. Miller Fisher Syndrome (MFS)
      • 4.4.2.3. Acute Motor Axonal Neuropathy (AMAN)
      • 4.4.2.4. Others
    • 4.4.3. Market Attractiveness Analysis: Syndrome Type
  • 4.5. Global Guillain-Barre Syndrome Diagnostics Market Outlook End-use
    • 4.5.1. Historical Market Size (US$ Mn) Analysis, By End-use, 2019-2024
    • 4.5.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
      • 4.5.2.1. Hospitals and Clinics
      • 4.5.2.2. Diagnostic Laboratories
      • 4.5.2.3. Research & Academic Institutes
      • 4.5.2.4. Specialty Neurology Centers
    • 4.5.3. Market Attractiveness Analysis: End-use

5. Global Guillain-Barre Syndrome Diagnostics Market Outlook Region

  • 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.2. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Latin America
    • 5.2.3. Europe
    • 5.2.4. East Asia
    • 5.2.5. South Asia and Oceania
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Guillain-Barre Syndrome Diagnostics Market Outlook

  • 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Diagnostic Type
    • 6.1.3. By Syndrome Type
    • 6.1.4. By End-use
  • 6.2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
    • 6.3.1. Lumbar Puncture
    • 6.3.2. Nerve Conduction
    • 6.3.3. Electromyography (EMG)
    • 6.3.4. Blood Test
    • 6.3.5. Other
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
    • 6.4.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
    • 6.4.2. Miller Fisher Syndrome (MFS)
    • 6.4.3. Acute Motor Axonal Neuropathy (AMAN)
    • 6.4.4. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    • 6.5.1. Hospitals and Clinics
    • 6.5.2. Diagnostic Laboratories
    • 6.5.3. Research & Academic Institutes
    • 6.5.4. Specialty Neurology Centers
  • 6.6. Market Attractiveness Analysis

7. Europe Guillain-Barre Syndrome Diagnostics Market Outlook

  • 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Diagnostic Type
    • 7.1.3. By Syndrome Type
    • 7.1.4. By Syndrome Type
    • 7.1.5. By End-use
  • 7.2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
    • 7.3.1. Lumbar Puncture
    • 7.3.2. Nerve Conduction
    • 7.3.3. Electromyography (EMG)
    • 7.3.4. Blood Test
    • 7.3.5. Other
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
    • 7.4.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
    • 7.4.2. Miller Fisher Syndrome (MFS)
    • 7.4.3. Acute Motor Axonal Neuropathy (AMAN)
    • 7.4.4. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    • 7.5.1. Hospitals and Clinics
    • 7.5.2. Diagnostic Laboratories
    • 7.5.3. Research & Academic Institutes
    • 7.5.4. Specialty Neurology Centers
  • 7.6. Market Attractiveness Analysis

8. East Asia Guillain-Barre Syndrome Diagnostics Market Outlook

  • 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Diagnostic Type
    • 8.1.3. By Syndrome Type
    • 8.1.4. By End-use
  • 8.2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
    • 8.3.1. Lumbar Puncture
    • 8.3.2. Nerve Conduction
    • 8.3.3. Electromyography (EMG)
    • 8.3.4. Blood Test
    • 8.3.5. Other
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
    • 8.4.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
    • 8.4.2. Miller Fisher Syndrome (MFS)
    • 8.4.3. Acute Motor Axonal Neuropathy (AMAN)
    • 8.4.4. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    • 8.5.1. Hospitals and Clinics
    • 8.5.2. Diagnostic Laboratories
    • 8.5.3. Research & Academic Institutes
    • 8.5.4. Specialty Neurology Centers
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Guillain-Barre Syndrome Diagnostics Market Outlook

  • 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Diagnostic Type
    • 9.1.3. By Syndrome Type
    • 9.1.4. By End-use
  • 9.2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Indonesia
    • 9.2.3. Thailand
    • 9.2.4. Singapore
    • 9.2.5. ANZ
    • 9.2.6. Rest of South Asia & Oceania
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
    • 9.3.1. Lumbar Puncture
    • 9.3.2. Nerve Conduction
    • 9.3.3. Electromyography (EMG)
    • 9.3.4. Blood Test
    • 9.3.5. Other
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
    • 9.4.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
    • 9.4.2. Miller Fisher Syndrome (MFS)
    • 9.4.3. Acute Motor Axonal Neuropathy (AMAN)
    • 9.4.4. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    • 9.5.1. Hospitals and Clinics
    • 9.5.2. Diagnostic Laboratories
    • 9.5.3. Research & Academic Institutes
    • 9.5.4. Specialty Neurology Centers
  • 9.6. Market Attractiveness Analysis

10. Latin America Guillain-Barre Syndrome Diagnostics Market Outlook

  • 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Diagnostic Type
    • 10.1.3. By Syndrome Type
    • 10.1.4. By End-use
  • 10.2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
    • 10.3.1. Lumbar Puncture
    • 10.3.2. Nerve Conduction
    • 10.3.3. Electromyography (EMG)
    • 10.3.4. Blood Test
    • 10.3.5. Other
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
    • 10.4.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
    • 10.4.2. Miller Fisher Syndrome (MFS)
    • 10.4.3. Acute Motor Axonal Neuropathy (AMAN)
    • 10.4.4. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    • 10.5.1. Hospitals and Clinics
    • 10.5.2. Diagnostic Laboratories
    • 10.5.3. Research & Academic Institutes
    • 10.5.4. Specialty Neurology Centers
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Guillain-Barre Syndrome Diagnostics Market Outlook

  • 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Diagnostic Type
    • 11.1.3. By Syndrome Type
    • 11.1.4. By End-use
  • 11.2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Type, 2025-2032
    • 11.3.1. Lumbar Puncture
    • 11.3.2. Nerve Conduction
    • 11.3.3. Electromyography (EMG)
    • 11.3.4. Blood Test
    • 11.3.5. Other
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Syndrome Type, 2025-2032
    • 11.4.1. Acute Inflammatory Demyelinating Polyneuropathy (AIDP)
    • 11.4.2. Miller Fisher Syndrome (MFS)
    • 11.4.3. Acute Motor Axonal Neuropathy (AMAN)
    • 11.4.4. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Research & Academic Institutes
    • 11.5.4. Specialty Neurology Centers
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Cadwell Industries, Inc,
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Sources
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Alpine Biomed
    • 12.3.3. Bionen Medical Devices
    • 12.3.4. Cardinal Health
    • 12.3.5. Clarity Medical
    • 12.3.6. Deymed Diagnostic
    • 12.3.7. EMS Biomedical
    • 12.3.8. Medtronic
    • 12.3.9. Natus Medical Incorporated
    • 12.3.10. Nihon Kohden
    • 12.3.11. Rochester Electro-Medical (LifeSync)
    • 12.3.12. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations